Cargando…
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis
INTRODUCTION: Progression of joint destruction in rheumatoid arthritis (RA) is partly heritably; 45 to 58% of the variance in joint destruction is estimated to be explained by genetic factors. The binding of RANKL (Receptor Activator for Nuclear Factor κ B Ligand) to RANK results in the activation o...
Autores principales: | Knevel, Rachel, de Rooy, Diederik PC, Saxne, Tore, Lindqvist, Elisabet, Leijsma, Martha K, Daha, Nina A, Koeleman, Bobby PC, Tsonaka, Roula, Houwing-Duistermaat, Jeanine J, Schonkeren, Joris JM, Toes, Rene EM, Huizinga, Tom WJ, Brouwer, Elisabeth, Wilson, Anthony G, van der Helm-van Mil, Annette HM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060386/ https://www.ncbi.nlm.nih.gov/pubmed/24886600 http://dx.doi.org/10.1186/ar4558 |
Ejemplares similares
-
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
por: De Rooy, Diederik PC, et al.
Publicado: (2011) -
Integration of gene ontology pathways with North American Rheumatoid Arthritis Consortium genome-wide association data via linear modeling
por: Lebrec, Jérémie JP, et al.
Publicado: (2009) -
Does pathway analysis make it easier for common variants to tag rare ones?
por: Uh, Hae-Won, et al.
Publicado: (2011) -
Pathway analysis for family data using nested random-effects models
por: Houwing-Duistermaat, Jeanine J, et al.
Publicado: (2011) -
Secondary phenotype analysis in ascertained family designs: application to the Leiden longevity study
por: Tissier, Renaud, et al.
Publicado: (2017)